Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.
Innovex International, Inc.
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-62.8% vs price
Base Case (Median)
-51.6% vs price
Bull Case (75th pct.)
-15.2% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $9.16 | -69.3% | High (40%) |
| PE Comparable | $11.01 | -63.1% | Medium (25%) |
| Graham Number | $17.55 | -41.2% | Medium (40%) |
| EV/EBITDA | $27.89 | -6.5% | Medium (20%) |
| EV/FCF | $36.33 | 21.7% | Medium (20%) |
| Earnings Power Value | $11.36 | -61.9% | Medium (50%) |
Based on 6 out of 8 methods, INVX appears overvalued at the current price of $29.84. The base case fair value of $14.45 implies 51.6% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.
